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Cadherins are transmembrane glycoproteins that are involved in maintaining integrity of cell 
junctions, morphogenesis, cell sorting and many more important biological processes. In my 
thesis, I have focused on studying the binding affinity of a class of cadherin superfamily called N-
cadherins. Prior studies have demonstrated that N-cadherins can promote neuronal growth and 
axonal regeneration in vitro. Moreover, there is a growing interest in development of small 
molecules targeting N-cadherins and designing of therapeutic agents to promote cell survival and 
axonal regeneration as well as inhibit cadherin mediated signaling. For in vitro studies, knowing 
the minimum fragments of adhesive binding domain i.e. extracellular domains that can recapitulate 
the wild type N-cadherin binding functions can help develop designing of biomaterials and 
platforms to study N-cadherin interactions. Two dimensional affinity measurements reveal 
probability of stable bond formation during homophilic and/or heterophilic interactions between 
cadherins via extracellular domains. In order to determine the minimum fragment of the 
extracellular domain required for binding to mimic full length cadherin and wild type cadherins 
expressed on cell surfaces, Micropipette Aspiration Assay (MPA) was performed. Using N-
cadherin as a model for classical cadherins, the binding affinity of full length N-cadherin (N-cad 
EC1-5) expressed on a test cell surface (here, mesenchymal stem cell (MSCs) with the first two 
extracellular domains (N-cad EC1-2) and the binding pocket sequence HAVDI peptide and full 
length N-cadherin (N-cad EC 1-5) were measured by this assay. The first chapter of my thesis, I 
talked about the structural differences of most studied cadherins E and N-cadherins and briefly 
described the importance of the flanking amino acid of binding pocket sequence HAVDI in N-
cadherins. In the following chapter, I describe the experimental approach for determining the 
binding affinities of N-cadherin fragments and compared the 2D binding affinity results with that 
of the full length wild type N-cadherin expressed on MSCs. Surprisingly, the results of the study 
revealed that there is no significantly difference in binding affinity between N-cad EC1-2 and N-
cad EC1-5 as well as HAVDI and N-cad EC1-5. The MPA studies were conducted with both wild 
type MSCs expressing N-cad EC1-5 as well as RBCs modified with N-cad EC1-5. However, there 
is a lower binding affinity between E-cadherin and HAVDI than that between N-cadherin and 
HAVDI. These results demonstrate the importance of the flanking amino acids next to HAV 
sequence in cadherin specificity as well as the possible application of small peptide sequence 
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Chapter 1: Introduction to cadherins 
1.1 Background  
Cadherins are single-pass transmembrane glycoproteins that belong to a superfamily of adherens 
junction protein. Cadherins form adhesive binding interfaces between cells and perform like a 
Velcro. The binding specificity of cadherins plays an important role in maintaining cell-cell 
contacts and tissue barrier integrity (Takeichi et al., 1994; Gumbiner, 2005; Niessen et al., 2011; 
Nagafuchi et al., 1987; Takeichi, 1991). Depending on the activation pathway of intracellular 
signal transduction in cells, cadherins are also involved in axonal growth, synaptic plasticity and 
cell migration (Williams et al., 2002). Morphological changes during tissue development are 
accompanied by changes in expression levels of different types of cadherins (Gumbiner, 1996). 
Depending on tissue specific expression patterns, cadherins can promote epithelial, endothelial or 
neuronal cell adhesion. The tissue-specific expression of cadherins during embryogenesis is also 
highly regulated. Therefore, understanding how the intercellular contacts are maintained and 
regulated gives us insight to the fundamental mechanism of tissue development as well as 
impairment of function during disease.  
1.2 Cadherin structure and functions 
The type I “classical” cadherins are the most studied cadherins. They share a common structure 
consisting of a cytoplasmic domain, a transmembrane domain and five extracellular domains 
(EC1-5, where EC1 being the outermost, N-terminal domain) which contains the adhesive 
interface.  Each extracellular domain is comprised of ~110 amino acids, and three Ca2+ ions bind 
at each junction between the consecutive EC domains, and are thought to help in rigidifying the 
structure and in maintaining function (Shapiro et al., 1995). The single pass transmembrane 
segment is an alpha helix consisting of 34 amino acids. The intrinsically disordered cytoplasmic 
domain binds to cytosolic proteins called catenins that are involved in actin coupling and signaling. 
The first two extracellular domains EC1-2 contain the adhesive domain, and are involved in trans-
dimerization between cadherins from apposing cell surfaces. The N-terminus of EC1 domain 
comprises of 10 amino acid sequence, including ‘DWVI’ sequence that is highly conserved 
throughout all type I cadherins (Ozawa and Kemler, 1990; Handschuh et al., 2001). 
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 The first extracellular domain (EC1) of cadherins forms the adhesive binding domain, and it is a 
sequence within EC1 consisting of His-Ala-Val (HAV) is evolutionarily conserved across speciess 
consisting of His-Ala-Val (HAV) motif. The adhesive interface is formed by the trans-dimer or 
the strand-swapped dimer is formed, and occurs when a side chain from Trp2 (W2) residue is 
inserted into a complementary hydrophobic pocket on EC1 of the apposing protein (Vendome et 
al., 2011; Vendome et al., 2014). Examples of classical cadherins are: N-cadherin or neuronal 
cadherin, which is usually expressed on neural cells (Peuloso et al., 1996;  Gumbiner, 2000) 
endothelial, and invasive cancer cells; E-cadherin or epithelial cadherin, which is predominantly 
expressed by epithelial cells; P-cadherin (origin: placenta) which is expressed in extra-embryonic 
ectoderm and visceral endoderm (Vieira and Paredes, 2015).  
1.3 Differences between N and E-cadherin binding pocket 
High-resolution crystal structures of the N-cadherin extracellular region and mutagenesis studies 
showed that EC1 is critical for cell-cell adhesion, and both the W2 residue and HAV motif are 
critical for cadherin mediated adhesion (Leckband and Prakasam, 2006).  
Although  highly  conserved  across  species,  the  binding  pocket  sequence  of  N-cadherin  is  
different  from  that  of  E-cadherin.  The  extracellular  domain  (EC-1)  of  N-cadherin  has  the  
sequences  ‘HAVDI’  and  ‘INPISGQ’  that are identified  as two important binding  motifs (Skaper  
et  al. , 2004).  The crystal  structure  of  the N-cadherin  adhesive  dimer  interface  revealed  that  
the  INPI  sequence  in  one  monomer  is  in  close  contact  with  the  VDI  sequence  in  the  
second  monomer,  and  thus  forms  the  binding  pocket.  Both  ‘INPI’  and  ‘VDI’  sequences 
were identified as  key  residues  at  the  N-cadherin  dimer  interface (Williams et al.  2000).  
While  HAV  is  involved  in  the  adhesive  domain  formation,  the  amino  acid  sequence  next  
to  it  is  also  important.  Makagiansar et al.  (2001)  showed, using trans epithelial electrical 
resistance measurements  that  binding  between  E-cadherins  can  be  modulated  by  changing  
the  amino  sequence  followed  by  the  HAV  sequence. In this study, the modulation of 
intercellular junctions of MDCK (Madin-Darby Canine Kidney) cells were evaluated by 
measuring the ability to lower the transepithelial electrical resistance (TEER) of cell monolayer 
cultured on Transwell™ membranes. For example, Ac-SHAVAS-NH2 and  Ac-SHAVSA-NH2  
were  more  effective  than Ac-SHAVSS-NH2  at mimicking  the  binding  pocket  sequence  of  
E-cadherin. Therefore, although the HAV sequence is a primary binding motif for all of the 
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classical cadherins, the selectivity is postulated to be determined by the flanking amino acids, 
which differ among the classical cadherins.  
1.4 Importance of the first two extracellular domains of classical cadherins in forming 
adhesive binding pocket 
Over the years there have been several reports on the discovery of a second cadherin interface 
other than that involving the trans-dimerization, which was later known as the X-dimer. The crystal 
structure of N-cadherin with an unprocessed N-terminal methionine revealed an inactive form of 
EC1-2 which was the first evidence on an X-dimer structure (Nagar et al., 1996). Later, a W2A 
mutant of E-cadherin as well as the EC1-2 fragment of a non-classical, truncated T-cadherin, the 
similar X-dimer was crystallized by Ciatto et al. (2010). Structural studies done with Surface 
Plasmon Resonance (SPR) and Analytical Ultracentrifuge (AUC) by Harrison et al. (2010) showed 
that X-dimers are formed when strand swapping is prevented by mutations in E-cadherin (K14E 
mutant) and that X-dimer increases activation barrier in the dimerization pathway but it doesn’t 
affect the dissociation constant, KD. Single-bond rupture measurements with AFM were performed 
based on lifetimes of single cadherin bonds between EC1-2 fragments subjected to constant 
applied force by Rakshit et al. (2012). This study identified the X-dimer as a catch bond, i.e. it 
ruptures more slowly (as its lifetime increases) at increasing force and therefore the bonds appear 
to be more stable at higher forces. On the other hand, the strand dimer is a slip bond i.e. it ruptures 
more quickly at increasing force and therefore, the bonds appear to be less stable and thus its 
dissociation rate increases.  
From these studies, it was postulated that the X-dimer could be an important intermediate in the 
strand-dimerization pathway that lowers the activation energy and accelerates the formation of 
more stable (lower-Kd) strand dimers (Leckband and Rooij, 2014; Hong et al., 2011).  
1.5 HAVDI sequence in N-cadherin binding pocket 
N-cadherin has important implications in a number of developmental events like neuronal cell 
adhesion, controlling axonal growth, guidance, synapse formation and synaptic plasticity (Bixby 
and Zhang, 1990; Fannon and Coleman, 1996; Tang et al., 1998). Thus, N-cadherin has been tied 
to both the process of inter-cellular adhesion as well as recognition and signal transduction 
function in neurons. More recently, peptide mimetics of the INPISGQ and HAVDI sequences have 
                                                                                                     4 
 
been shown to inhibit N-cadherin-stimulated neurite outgrowth, with IC50 values of ~15 and 65 
µM, respectively (Williams et al., 2000a). Based on this study, it was concluded that these two 
short peptide sequence have important involvement in homophilic recognition process that leads 
to neurite outgrowth response. Interestingly, both HAVDI and INPISGQ sequences are present at 
the trans-dimer interface i.e. EC1 domain of N-cadherins. Shapiro et al., (1995) have shown that 
the same recombinant EC1 protein will form two distinct crystal dimers; one has the characteristics 
of a trans-adhesion dimer (Protein Data Bank code 1NCH), and the second has the characteristics 
of a cis-dimer (code 1NCG).  
The HAV sequence in the first ectodomain of all classical cadherins has also been implicated in 
cadherin recognition (Boggon et al. 2002; Brasch et al. 2011). Even though the sequence lines the 
Trp-2 acceptor pocket, the buried Ala 80 points towards the hydrophobic core, and prevents the 
side chain from directly being involved in adhesion with a partner molecule. Therefore, it is 
postulated that Alanine 80 alone could not be involved in the formation of cis or trans dimer. 
Therefore, the Histidine and Alanine constitute of only 5% or less of the entire W2 binding 
interface (Shapiro et al., 1995). Moreover, the specificity of the sequence HAV for N-cadherin 
was demonstrated to be improved with the addition of aspartic acid (D) and isoleucine (I) to form 
a peptide motif containing HAVDI (Williams et al., 2000a). These observations raise questions 
whether HAVDI peptide can truly mimic N-cadherin-specific functions. 
In the first extracellular domain (EC1) of N-cadherin HAVDI and INPISGQ sequences have been 
identified as key binding pocket motifs by physiological relevant assays. Williams et al. (2002) 
demonstrated that N-Ac-CHAVDINGHAVDIC-NH2 peptide promotes neurite outgrowth by using 
a cyclic construct of HAVDI. Therefore, a dimeric version of short peptide HAVDI is capable of 
promoting survival of several population of central nervous system neurons.  
The amino acid sequence after the HAV sequence was identified to play a very important role in 
cadherin mediated adhesion. Previous work by Makagiansar et al.  (2001), it was demonstrated 
that by mutating the serine in the binding pocket sequence of E-cadherin, HAVSS to HAVSA or 
HAVAS, the specificity of E-cadherin binding can be improved. Moreover, the adhesive 
extracellular domain of E-cadherin does not have INPI motif which was found to be lie closely to 
the VDI in the binding pocket i.e. in the first extracellular domain of N-cadherins (Williams et al., 
2000; Williams et al., 2002). From crystal structures they demonstrated that the INPI sequence in 
                                                                                                     5 
 
one monomer is in close contact with the VDI sequence of the second monomer upon the formation 
of adhesive strand dimer interface involving the EC1 domains of two apposing cadherins, thereby 
making the E-cadherin less specific towards HAVDI motif.  
In recent years there is a great interest among scientists to discover small molecule inhibitors, 
soluble factors and/or extracellular matrix ligands in order to study or control the influence of 
microenvironments on stem cell behavior (McBeath et al., 2004; Yang et al., 2014). One example 
of this is the incorporation of an HAVDI peptide sequence from the EC1 domain of N-cadherin 
onto a methacrylated hyaluronic acid backbone (MeHA) in order to study intercellular interactions 
promoting chondrogenesis in vitro (Cosgrove et al., 2016). Moreover, in vitro studies related to 
neuronal growth, cadherin assembly, activation of cell signaling and to designing biomaterial 
platform for N-cadherin proliferation and fate commitment studies, biomaterials have been 
modified with either Fc-tagged N-cadherin extracellular domain (Vega et al., 2016; Yue et al., 
2010) or with peptides within the extracellular domain containing the histidine-alanine-valine 
(HAV) sequence (Lambert et al., 2000; Kwon et al., 2018). Studies in this field have demonstrated 
that both immobilized N-cad Fc and HAV have a role in N-cadherin dependent cell adhesion.  
1.6 Significance of 2D binding kinetics studies 
The adhesion processes sensitively depend on the binding rate constants for the membrane-bound 
receptor and ligand proteins that mediate adhesion. The ligand-receptor interactions of cadherins 
on two apposing cell surface are very specific which is better modeled by reaction kinetics (Bell, 
1978).  
There are many methods available for measuring binding kinetics, for example, 3D binding 
constants when at least one of the receptor-ligand pairs are in solution conducted in a flow chamber 
(Décavé et al, 2002) as well as, 2D binding kinetics when the receptor-ligand molecules are bound 
to two apposed surfaces as in the case of cell-cell or cell-substrate adhesion by micropipette 
aspiration assay (Chesla et al, 1998). In micropipette aspiration assay, a test cell is aspirated in one 
of the micropipettes and usually a red blood cell (RBC or Erythrocyte) is aspirated in another. 
These cells are then made to come in contact by a programmable piezo-electric controller for a 
definite period of time (0.5 s to 20s) and retracted to observe any adhesion that might have 
occurred. The test outcome is scored as 1 if any adhesion is observed and 0 if not. Thus, the 
adhesion probability, rather than adhesion strength is measured from the running frequency of 
                                                                                                     6 
 
binding events for receptor-ligand pairs (150 tests per contact duration). The kinetic rates i.e. 
forward and reverse reaction constants and the equilibrium binding constants i.e. affinities are 
extracted from the measured adhesion probability versus contact duration data of the aspirated 
molecules in question. RBCs are preferable because it provides a smooth cell surface when swollen 
completely, without any excess cell surface protrusion allowing  
The model that we have adopted for evaluating the binding interaction is McQuarrie’s (Cozens-
Roberts et al., 1990) probabilistic formulation of kinetics in small systems and the analytical 
solution of the master equations have been solved by Chesla et al. (1998). It describes the 
dependence of adhesion probability on the contact duration as follows, 
Pa= 1- exp {-𝐴𝐶𝑚𝑟𝑚𝑙𝐾𝐴
0[1 − exp(−𝑘𝑟
0𝑡)]} 
Where Ac is the contact area (µm
2), mR and mL are cadherin densities on the two cells 
(number/µm2), ka is the two-dimensional affinity (µm
2), and koff is the dissociation rate (seconds). 
Thus micropipette aspiration assay has been used to investigate the binding kinetics of cell-cell 
adhesion molecules quantitatively. 
1.7 Assumptions of 2D receptor-ligand binding kinetics model 
In the probabilistic model of binding kinetics, the following assumptions are made: adhesion is a 
random event i.e. whether or not binding occurs in a particular adhesion test is nondeterministic, 
even when all conditions are controlled by the experimenter, for example the contact area (Ac) and 
duration (t) of contact between the two cells, their respective surface densities (mr and ml) are kept 
identical. This is a good assumption since the randomness of adhesion events is due to the inherent 
stochastic nature of the receptor-ligand binding event. In order to correctly describe the system, a 
probability vector {p0, p1 , . . . ,pn, . . . , pAc,min}. Each possible scenario has a defined likelihood, 
e.g., given by pn for n adherent bonds.  
Therefore, the initial conditions are: 
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Meaning there is no bond at the instant when the two cells are just brought into contact with each 
other (t=0). As t>0, bonds start to form and pn(t) increases with contact time, t. The single-step 
receptor-ligand binding kinetics in general form is given by:  
 
Where, νr, νb, νl are the stoichiometric coefficients of the reactor (mr), product (mb) and ligand (ml) 
respectively. The rate of change of probability of forming n adherent bonds with respect to contact 
time is given by-  
𝑑𝑝𝑛
𝑑𝑡








































Two special cases can be considered:  
Case I: One of the molecular species outnumbers the other, then the reaction is limited by the 
availability of the species of density, mmin. By applying this approximation, the solution of the 
master equation can be described as a binomial distribution: 






Case II: the number of bonds that are formed in any given event, is much smaller than the numbers 
of available receptors and ligands.  
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Using the Case II approximations, Chesla et al. (1998) showed that the probability of binding for 
any given contact time, t is given by, 
 Pa= 1-p0 = exp {-𝐴𝐶𝑚𝑟𝑚𝑙𝑘𝐴
0[1 − exp(−𝑘𝑟
0𝑡)] }; where p0 is the probability that no bond is 
formed. Therefore, Pa= 1- exp {-𝐴𝐶𝑚𝑟𝑚𝑙𝐾𝐴
0[1 − exp(−𝑘𝑟
0𝑡)] }, when νr=νl =νb=1 
1.8 Questions addressed in this thesis  
Studies described in this thesis test the hypothesis that the HAV sequence is the minimal cadherin 
fragment required to mimic the functions of wild type N-cadherin. To test this, I have measured 
2D binding affinities of full length N-cadherin (N-cad EC1-5) and N-cadherin fragments (N-cad 
EC1-2 and HAVDI peptide) by Micropipette Aspiration Assay (MPA) and compared these values 
to understand the differences, if any.  In absence of any significant differences between the wild 
type N-cadherin and its fragments, it would imply the possibility of HAVDI peptide of being the 
minimum fragment required for mimicking full length N-cadherin mediated adhesion. Also, 
another hypothesis that we have tested is that the flanking amino acids of the HAV sequence in 
binding pocket affect the binding selectivity. To do so, the binding affinity of E and N-cadherin 
for HAVDI peptide were measured and compared. These measurements enables us to determine 
whether N-cadherin binding to its pocket sequence HAVDI is higher than the binding of E-
cadherin with HAVDI sequence. It may be noted that the binding pocket sequence of E-cadherin 
is HAVSS. In the following chapter, I have described the procedure of micropipette aspiration 
assay that has been used for quantification of binding affinity of N-cadherin fragments and how 
the binding probability vs. contact duration data was fit to a receptor-ligand binding kinetics model 
(described in section 2.6) in order to understand the minimum fragment required for cadherin 
mediated adhesion. In this study, I worked with three different N-cadherin fragments that are 
involved in  cadherin mediated adhesion, such as: 1) an Fc-tagged N-cadherin recombinant protein 
with all five ectodomains (N-cad EC1-5), 2) a biotinylated N-cadherin fragment containing EC1 
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Chapter 2: Investigation of minimum fragment requirement of N-cadherin for 
binding  
Given the importance of cadherin mediated biological processes, especially adhesion, there is a 
growing interest in development of novel agonists and/or therapeutic agents to promote cell 
survival and axonal regeneration as well as inhibit cadherin mediated signaling. To recapitulate N-
cadherin binding interactions in vitro, full length N-cadherins or HAV sequence have been used 
to modify biomaterials (Kwong et al., 2018). Moreover, there are studies showing that N-cadherin 
expressing cells can bind to immobilized N-cadherin Fc on surface, resulting in subsequent 
adhesion that triggered local, rapid assembly of cadherin/catenin complexes, activation of 
intracellular signaling and cytoskeletal reorganization (Bian et al., 2013). These studies 
demonstrate that N-cad Fc and HAVDI sequence support N-cadherin mediated adhesion, and 
possibly mechanosensing (Cosgrove et al., 2016).  
In this study, we explored the requirement of minimum fragments of a class of cadherin 
superfamily; N-cadherin in mimicking the binding interactions of full sized wild type N-cadherins. 
We studied three N-cadherin constructs, each representing structures that are postulated to be a 
part of cadherin mediated mechanosensing. They are following:  
A. Full length N-cadherin (N-cad EC1-5), which contains all five ectodomains of the 
extracellular domain. It is Fc-tagged, and therefore, it can be immobilized to red blood cells 
by an anti-Fc antibody.  
B. The N-cadherin fragment (N-cad EC1-2), which contains only the first two extracellular 
domains. It is biotinylated, and thus, it can be immobilized to red blood cells using 
streptavidin. 
C. Ac-HAVDIGGGKC peptide (HAVDI) sequence, which is found in the binding pocket of 
the EC1 domain. The thiol and amine groups of cysteine and lysine, respectively, can be 
used to immobilize the peptide to various surfaces. 
All three constructs have the potential to bind to W2 interfaces, while only N-cad EC1-5 Fc and 
N-cad EC1-2 (biotinylated construct) have regions containing the first two extracellular domain 
responsible for forming X-dimer, which is considered to be the kinetic intermediate in the reaction 
pathway for strand dimer formation. Only N-cad EC1-5 Fc has the regions that are required for 
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interactions attributed to lateral cluster formation (Prakasam et al., 2006). The HAVDI peptide, 
only represents the part of the binding pocket that is crucial in forming adhesive domain.  
The identification of the minimal N-cadherin fragment required to mimic the full length N-
cadherin binding function will help in designing N-cadherin-functionalized surfaces to promote 
neuron growth, understand stem cell perception of the tissue microenvironment.  
2.1 Materials and methods 
2.1.1 Production of Fc-tagged N-cadherin EC1-5 
Soluble, recombinant N-cadherin ectodomains with C-terminal Fc tags (N-cad EC1-5) were stably 
expressed in human embryonic kidney cells (HEK293, American Type Culture Collection), as 
previously described.7,14 Cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) 
containing 10 % (v/v) fetal bovine serum (FBS) and 0.4 mg/mL G418 (Sigma Aldrich) as a 
selection marker. The cell culture supernatant containing the recombinant N-cadherin protein was 
collected every two to three days, and later filtered and purified using a protein-A affinity column 
(Bio-Rad) followed by gel filtration chromatography (HiPrep 16/60 Sephacryl S-200 HR, Sigma-
Aldrich) using the AKTA pure protein purification system. Protein purity was assessed using 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). 
2.1.2 Biotinylated N-cadherin EC1-2 expression and purification1 
The plasmid encoding the BirA ligase was a gift from Dr. John E. Cronan (University of Illinois 
at Urbana Champaign). The plasmid is chloramphenicol resistant and carries the BirA gene under 
the control of the araBAD promoter. The N-cad EC1-2 plasmid was constructed by introducing a 
sumotag, the first two ectodomains of N-cadherin, and an avitag in a pRSET-A vector backbone 
with an N-terminal 6XHis tag. The sumotag was PCR amplified from pRSF- KpDcr1 (Addgene) 
with a BamH1 and Kpn1 restriction sites at N- terminal and C-terminal respectively, and the N-
cad EC1-2 was PCR amplified from the human full-length N-cadherin plasmid (Salomon et al., 
1992) with Kpn1 and Nhe1 restriction sites at N- terminal and C-terminal respectively. Finally, an 
Avitag with stop sequence was added as a linker with Nhe1 and EcoR1 restriction sites at N- 
terminal and C-terminal respectively. The whole sequence was cloned into the BamH1 and EcoR1 
1The expression and purification of N-cad EC1-2 was done by Ellen C. Qin, Dept. of Material Science and Engineering, 
University of Illinois at Urbana-Champaign.  
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site of pRSET-A vector. Escherichia coli BL21 (DE3) cells co-expressing the His6-tagged 
fragment containing the N-cadherin extracellular domains 1-2 (His6-N-cad EC1-2) and birA ligase 
were grown at 37°C in Lennox LB media supplemented with 5 mg/L of L-(+)-arabinose (Sigma 
Aldrich), 0.01% w/v biotin (Sigma Aldrich), 0.1 mg/mL ampicillin and 25 mg/mL 
chloramphenicol overnight. sulfosuccinimidyl 6-(40-azido-20-nitrophenylamino)hexanoate 
bacterial culture was diluted in fresh LB medium at a ratio of 1:100 with the above supplements. 
When the OD of the bacterial culture reached 0.4-0.6, isopropyl β-D-1-thiogalactopyranoside 
(IPTG) was added to the culture to a final concentration of 0.5 mM to induce the production of 
His6-N-cad EC1-2. After 4 hours, the bacterial cultures were pelleted by centrifugation at 8,000 
rpm for 10 min using a Sorvall RC-5C Plus centrifuge equipped with a GS3 rotor and frozen at -
20 °C. The frozen pellets were thawed and resuspended in lysis buffer composed of Bugbuster® 
protein extraction reagent (3 mL/g wet weight of pellet, Millipore) supplemented with 1 mg/mL 
lysozyme (Sigma Aldrich) and 1x complete EDTA-free protease inhibitor cocktail (Roche, 
Mannheim, Germany) on ice. After 15 min, the culture was probe sonicated for four cycles with 
15 sec bursts on ice and 30 sec intervals for cooling. The cell lysate was clarified by centrifugation 
at 15,000 rpm for 30 min using a Sorvall RC-5C Plus centrifuge equipped with an SS34 rotor. The 
supernatant was loaded onto an Ni-NTA agarose column (Qiagen) that was previously equilibrated 
in binding buffer (20 mM Tris - pH 7.4, 10 mM NaCl, 2 mM CaCl2). The column was rinsed with 
wash buffer (20 mM Tris - pH 7.4, 500 mM NaCl, 2 mM CaCl2, and 20 mM imidazol) to remove 
unbound protein. The His6-N-cad EC1-2 bound to the column was eluted with elution buffer (20 
mM Tris - pH 7.4, 50 mM NaCl, 2 mM CaCl2, and 250 mM imidazole). The eluted His6-N-cad 
EC1-2 was concentrated and the buffer was exchanged with phosphate buffered saline containing 
calcium (cPBS) using a 10 kDa MWCO centrifugal filter (Millipore, Darmstadt, Germany). The 
N-terminal His6-tag was cleaved from the soluble His6-N-cad EC1-2 protein using Small 
Ubiquitin-like Modifiers (SUMO) Protease (McLab). The reaction was performed in 1X SUMO 
Protease buffer (500 mM Tris-HCl, pH 8.0, 2% Ipegal, 10 mM DTT) with 1 unit enzyme for every 
2 µg of protein at 4 °C for two hours. The mixture was transferred to a Ni-NTA column, which 
bound the cleaved His-tag and uncleaved protein, and the the resulting biotinylated N-cadherin 
fragment (NEC1-2-biotin) was eluted from the column. The purity of the resulting NEC1-2 was 
determined by sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE), and the 
concentration was measured using a bicinchoninic acid (BCA) assay kit (Thermo Scientific). 
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2.1.3 HAVDI peptide purification2 
The small N-cadherin mimetic peptide (Ac-HAVDIGGGKC) and a scrambled peptide control 
(Ac-AGVGDGGGKC) were purchased from Mimotopes. A Cy5 maleimide-reactive dye (GE 
Healthcare) was used to fluorescently label the cysteines on each of the peptides. The peptides 
were dissolved in PBS to 2 mg/mL and reacted with the dye at a 1:2 peptide to dye molar ratio, for 
2 hours at room temperature. NHS-LC-biotin (ThermoFisher Scientific) was used to biotinylate 
the peptides through the lysine group. The peptides were dissolved in PBS at a concentration of 2 
mg/mL, and reacted with NHS-LC-biotin at a 1:2 peptide to biotin molar ratio, for 30 min at room 
temperature. The unconjugated dye and unreacted NHS-LC-biotin were removed from the peptide 
using high-performance liquid chromatography (PerkinElmer Flexar), and the final products were 
analyzed using low resolution electrospray ionization (ESI) Mass Spectrometry (Waters Quattro 
II). 
2.2 Quantification of N- and E-cadherin densities on cell surfaces  
The densities of immobilized or expressed cadherin densities on cell surfaces was quantified by 
flow cytometry, as previously described (Chesla et al., 1998 and Chien et al., 2008). MSCs were 
labeled with primary antibody (1:200); rabbit polyclonal N-cadherin antibody (Protein Tech, 48 
ug/150 ul), followed by the secondary Cy5TM labeled, goat anti-rabbit antibody (Invitrogen, 2 
mg/ml) at a dilution of 1:400. The cells were washed with twice with 1X Phosphate Buffered 
Saline (PBS) before and after the incubation with the secondary antibody in order to remove the 
unbound, excess antibodies. To determine the surface density of E-cadherin on MSCs, the cells 
were first labeled with primary, rat anti-E-cadherin antibody (DECMA-1, Sigma-Aldrich, St 
Louis, MO) at 1:300, followed by washing with 1X PBS (twice) and then incubation with 
secondary antibody goat anti-rat IgG-Alexa 647 (Abcam, 2 mg/ml) at 1:400. Approximately 105 
cells were used for labeling and incubation with both primary and secondary antibodies. 
Incubations were done in a cold room at 40°C for ~45 mins. The labeling was performed in 
Dulbecco’s Phosphate Buffer Saline (DPBS) with 0.9 mM calcium. The fluorescence intensity of 
labeled cells and of the standardized calibration beads for Alexa 647 (Bangs Laboratories, Inc., 
IN) were quantified using an LSR II flow cytometer (BD Biosciences, San Jose, CA).  
2The fluorescent labeling and purification of HAVDI peptide were done by Ellen C. Qin, Dept. of Material Science and 
Engineering, University of Illinois at Urbana-Champaign.  
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The fluorescence intensities were converted to total bound cadherin densities on the cells using the 
calibration curves according to the manufacturer’s instructions (Zhang et al., 2005). 
 
2.3 Isolation and modification of red blood cells  
Whole blood was collected from healthy donors at Community Blood Services of Illinois (CBSI) 
and red blood cells were isolated and purified from whole blood by a protocol reviewed and 
approved by the Institutional Review Board (IRB; protocol # 08669), as previously described 
(Langer et al., 2012). 
The anti-mouse Fc IgG (Sigma-Aldrich), the streptavidin-Alexa 647 (Thermo Fisher Scientific) 
were used to covalently bind N-cad EC1-5 or biotinylated N-cad EC1-2, respectively to the RBCs. 
These capture proteins are covalently coupled to glycoproteins on the RBCs surface that were 
chemically activated by CrCl3 treatment (Gold and Fudenberg, 1967; Kofler and Wick, 1977). 
Approximately 10 million RBCs were washed five times with 0.9 (w/v)% NaCl and resuspended 
in 0.9 (w/v) % NaCl solution. The primary antibody (either anti-mouse Fc IgG or the streptavidin-
Alexa 647 conjugate) was added to RBC solution typically at 10 µg/ml (Chesla et al., 1998). Then, 
serial dilutions of CrCl3 were prepared from 0.1 (v/v) % CrCl3 solution in 0.02 mM sodium acetate 
and 0.9 (w/v) % NaCl in separate microcentrifuge tubes. The CrCl3 solution was added to the RBC 
containing salt solution to allow for the coupling reaction (reaction time is 5 minutes). The cells 
were washed twice with phosphate buffer saline (PBS) containing 5 mM EDTA and 1 w/v% 
bovine serum albumin (BSA) and finally resuspended and stored in erythrocyte storage buffer 
called EAS 45 buffer, formulated by Zarnitsyna and Zhu (2011). In this reaction, the resulting 
density of antibodies immobilized to the cell surface was controlled by titrating the CrCl3 solution.  
The surface density of the anti-mouse Fc IgG was determined by flow cytometry using the 
secondary antibody goat anti-mouse IgG-Alexa 647 (Invitrogen). The labeling was performed in 
Dulbecco’s Phosphate Buffer Saline (DPBS) with 0.9 mM calcium with an incubation period of 
45 minutes at 40C. The molecules of equivalent soluble fluorochrome (MESF) values 
(approximately the number of antibodies) determined from flow cytometry, were converted into 
surface density of cadherins on RBCs (cadherins/area), assuming two cadherins bind to one IgG 
antibody. The estimated surface area of RBCs is ~168 µm2.   
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For determining N-cad EC1-2 and HAVDI peptides (both in biotinylated form) on RBCs, the 
RBCs were labeled with streptavidin Alexa 647 conjugate (Degree of labeling ~3 
dyes/streptavidin). Both the biotinylated N-cad EC1-2 and the HAVDI peptide were incubated 
with ~400,000 cells immobilized with streptavidin for 45 mins at 40 C before performing the flow 
cytometry. In order to estimate the density of N-cadherin fragments on RBCs, it was assumed that 
two out of four active sites of streptavidin were exposed for conjugation. Therefore, two N-cad 
EC1-2 or two HAVDI peptide were assumed to bind each streptavidin molecule.  It is possible that 
fewer proteins/peptides were bound, but that would increase the affinities estimated from the 
adhesion frequency data. 
For experiments where both biotinylated N-cad EC1-2 and HAVDI were immobilized on RBCs, 
DiI and DiO dyes were used to distinguish RBCs displaying the EC1-2 and HAVDI ligands, 
respectively. DiO is a carbocyanine membrane dye (yellow-orange dye, MW: 882) with a green 
fluorescent emission (excitation/emission spectra=484/501nm), and DiI is similar to 
tetramethylrhodamine (red-orange dye, MW: 933.8793, excitation/emission spectra is 
549/565nm).  Both dyes were purchased from Vybrant DiO Cell Labeling Solution from Thermo 
Fisher Scientific. 5 µL of the cell-labeling solution was added per mL of cell suspension, according 
to the recommendation by the manufacturer.  
In order to identify the red blood cells that were labeled with N-cad EC1-2 and HAVDI ligands, 
the DiO or DiI dye were used to label the latter two populations of cells, respectively. This was 
done in order to avoid picking cells that were either devoid of any N-cadherin fragments (i.e. bare 
RBCs) or or that were coated with the same ligand.  
2.4 Micropipette aspiration assay (MPA) to study 2D binding kinetics 
In order to quantify the interactions between N-cadherin fragments and N-cadherin expressed on 
MSCs, the binding kinetics and binding constants were determined using the micropipette 
adhesion frequency assay. The binding kinetics between cells displaying full-length N-cadherin 
and its fragments were quantified with micropipette adhesion frequency measurements, as 
described previously (Chien et al., 2008; Langer et al., 2012). In micropipette measurements, a test 
cell is aspirated in one of the micropipettes and a red blood cell (RBC or Erythrocyte) is held in 
the opposing micropipette. These cells are then brought into contact with a programmable piezo-
electric controller for a definite period (0.5 s to 40s) and then separated (Figure 2.1). The test 
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outcome is scored 1 if adhesion is observed and 0 if not. Thus, the adhesion probability, and not 
the adhesion strength, is determined from the running frequency of binding events for receptor-
ligand pairs (150 measurements per contact duration). The dissociation rate and steady state 
binding constants are extracted from model fits to the measured adhesion probability versus 
contact duration. The model adopted for evaluating the binding interaction is based on 
McQuarrie’s (Cozens-Roberts et al., 1990) probabilistic formulation of kinetics in small systems. 
For a simple second order binding reaction, the analytical solution of the master equations derived 
by Chesla et al. (1998) describes the time-dependence of the adhesion probability as: 
Pa= 1- exp{-AcmrmlKa[1-exp(-kofft)]}                    Eq.1 
where Ac is the contact area (µm
2), mr and ml are cadherin densities on the two cells (number/µm
2), 
Ka is the two-dimensional affinity (µm
2), and koff is the dissociation rate (seconds).  
The binding occurs between endogenous N-cadherin expressed on MSCs and the N-cadherin 
fragments (see above) immobilized on the RBCs. The binding kinetics between different N-
cadherin fragments can also be probed with two RBCs with the immobilized cadherin constructs 
on the surface. The cells were kept in a hypotonic L-15 medium (Leibovitz's L-15 Medium, 
(Invitrogen, Carlsbad, CA) containing 2.0 mM CaCl2 diluted 1:1 with deionized water to maintain 
a rounded form. Cells were observed with a 100x oil immersion objective on a Zeiss Axiovert 200 
microscope, interfaced with CCD camera (Pike, Allied Vision Technologies). The contact area 
was controlled at ~ 7.2 µm2.  
For each cell-cell contact time, three different cell pairs were subjected to 50 cell-cell touches (NT= 
50), in order to determine the binding probability, which is the ratio of the number of adhesion 
events and total cell-contacts (i.e. P= nb/NT). The binding probability reflects the number of stable 
bonds formed (Chesla et al., 1998). Reported probabilities are the average and standard deviation.  
2.5 Statistical analysis: Model fits to the EC1-mediated binding step 
The initial increase in the kinetic profile obtained from binding probability vs. contact time is due 
to trans-dimerization and is described by a kinetic model (Eq. 1) (Figure 2), but the more complex 
kinetic behavior requires the full ectodomain for all classical cadherins that have been studied 
(Barry et al. 2014, Chien et al. 2008, Tabdili et al. 2012). Thus, the first, fast rising to low 
probability stage p1 is fitted to the model involving only EC1-2 (fit shown by the dotted line in all 
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figures) and the slow rising phase to a higher probability stage, p2 is not fitted, which involves all 
EC1-5 domains (Figure A2.2). This two stage kinetics is typical of the binding kinetics exhibited 
by classical cadherins like E and N-cadherins.    
The measured contact time dependent adhesion probability data was fitted to Eqn. 1 by using 
Levenberg Marquadt algorithm for performing nonlinear, least squares regression in OrginLab 
program (Northampton. MA). For each contact time, the adhesion probability was measured with 
three different cell pairs. The best, unbiased estimated parameter is determined by weighted non-
linear least squares fit of the data to Equation 1, with the weighting factor for each time point being 
the inverse of the variance at that time point.  
A non-linear lack-of-fit test (Neill, 1988) identified the time points associated with the first, EC1 
strand swapping step. The test compares the model’s residuals to the inherent variability in the 
data, normalized to an F-distribution, as described by Langer et al. (2012).  
        Eq. 2 
For this test statistic, n is the number of distinct time points observed, ni is the number of 
observations at each time point, means the average value of observations at time point i, refers to 
the model prediction at time point i, refers to each individual measurement, and N is the total 
number of observations. 
A Student’s t-test was performed in order to determine the statistical significance of differences 
between 2D affinities measured, for given mean, standard error of mean (SEM) and number of 
observations (N). 
2.6 Results  
2.6.1 Binding affinities between cell surface N-cadherin and N-cadherin fragments 
The two-dimensional binding affinity between two red blood cells ectopically modified with N-
cadherin EC1-5 and another N-cadherin fragment was determined from micropipette adhesion 
frequency measurements (Figure 2.3 and Table 2.2). Similar to previous observations, the 
binding probability versus cell-cell contact measured between N-cadherin EC1-5 extracellular 
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domains on opposing cells exhibited a distinct two-stage kinetic signature, which is a general 
feature of type I classical cadherins (Chien et al., 2008; Tabdili et al., 2012). In Figure 2.3, the 
binding probability between identical N-cadherin EC1-5 fragments on opposing cells exhibits a 
rapid rise to an initial plateau at P~0.32. This is followed by a brief lag, and then a second increase 
in binding probability to a final steady-state plateau at P~0.45. Prior studies with domain deletion 
mutants 40 showed that the initial binding step requires the EC1 domain, and is due to formation 
of the strand swapped dimer (Ciatto et al., 2010; Harrison et al., 2010; Nagar et al., 1996; Rakshit 
et al., 2012). The second step requires the EC3 domain 40, and correlates with the formation of 
cadherin clusters at cell-cell junctions. Consistent with prior findings, the two-stage binding 
kinetics were not observed in measurements between N-cadherin EC1-5 and either N-cadherin 
EC1-2 or HAVDI (Figure 2.3). In both of the latter cases, the kinetic data exhibit a monotonic rise 
to a single plateau.  
To determine the binding affinity for initial bond formation (strand swap dimer), the analyses 
focused on the first binding step, which requires the EC1 domain. Data fits to Eq. 1 were used to 
estimate the two dimensional EC1-EC1 binding affinity and dissociation rate. In measurements 
between EC1-5 domains, a non-linear lack-of-fit test (Neill, 1988) identified the time points 
associated with the first, EC1 dependent binding step (strand swap). The test compares the model’s 
residuals to the inherent variability in the data, normalized to an F-distribution, as described by 
Langer et al. (2012). For all other kinetic data, which exhibited a single monotonic increase, data 
were fit to Eq. 1 (see Methods). Importantly, differences in the amplitudes of the initial plateau are 
due, in part to differences in cadherin densities on the cells, as demonstrated by the data fits. 
The best-fit, two-dimensional (2D) binding affinities and dissociation rates for each cadherin 
combination are summarized in Table 2.2. Measurements with the RBCs alone (Figure 2.3) 
quantified the N-cad binding alone. The best-fit, 2D affinity between N-cad EC1-5 and N-cad 
EC1-5 is 4.1 ± 0.1 x 10-5 µm2. Binding between EC1-5 and EC1-2 did not exhibit two-stage 
binding kinetics, but the best fit binding affinity was 4.06 ± 0.08 x 10-5 µm2, which is statistically 
similar that determined for EC1-mediated binding between N-cad EC1-5 (p>0.05 and n=3) 
somewhat surprisingly, N-cad EC1-5 bound HAVDI with an affinity of 4.22 ± 0.07 x 10-5 µm2, 
which is similar to the other two N-cad EC1-5 interactions (p>0.05 and n=3).  
                                                                                                     18 
 
The two-dimensional binding affinities were then measured between the cadherins expressed by 
MSCs and N-cadherin fragments immobilized on an opposing RBC (Figure 2.2 and Table 2.1). 
N-cad EC1-5 binding to cadherin on the MSC also exhibited two-stage kinetics, but fits of data 
corresponding to the initial binding step gave an apparent affinity of 4.06 ± 0.08 x 10-5 µm2, which 
is statistically similar to the affinity between N-cad EC1-5 fragments (p>0.05 and n=3). Likewise, 
N-cad EC1-2 binding kinetics exhibited a rise in probability to a single plateau, and the best fit 2D 
affinity is 4.0 ± 0.1 x 10-5 µm2. MSCs also bound HAVDI with an apparent affinity of 4.16 ± 0.8 
x 10-5 µm2, which is also similar to that determined with N-cad EC1-5 (p>0.05 and n=3)..  
MSCs express both N-cadherin and E-cadherin, with the surface density of E-cadherin being 7±3 
cadherin/µm2, (n=7) as determined by flow cytometry. Prior studies have shown that cadherins 
also form heterophilic trans bonds (Katsamba et al., 2009; Prakasam et al., 2006; Tabdili et al., 
2012). Therefore, to confirm whether E-cadherins expressed on MSCs contribute to the measured 
N-cadherin affinities, control measurements were done in which E-cadherin on the MSCs was 
blocked with anti-E-cadherin DECMA-1. Under these conditions, the measured affinity between 
MSCs and red blood cells modified with N-cad EC1-5 (53 cadherin/µm2) was 4.06 ± 0.02 x10-5 
µm2. The latter is not significantly different from the measured affinity in the absence of DECMA-
1 (4.04 ± 0.02 x10-5 µm2, p>0.05, n=3 replicates). Likewise, the binding affinity measured between 
MSCs blocked with DEMCA-1 and red blood cells modified with the HAVDI peptide (4.16 ± 0.08 
x10-5 µm2, p>0.05, n=3 replicates) was similar to that determined without DECMA-1 (4.1 ± 0.2 
x10-5 µm2). These results indicate E-cadherins that are expressed on MSCs have an insignificant 
contribution to the overall binding affinity determined with N-cadherin fragments. These results 
are summarized in Table 2.5.  
To determine whether E-cadherin binds to MSCs, a control experiment was performed between 
E-cadherin on RBCs and MSCs that were pretreated with anti-E-cadherin blocking antibody 
(DECMA-1) (Figure 2.5 and Table 2.4). When E-cadherin on MSCs is blocked, the cells bind 
due to heterophilic binding between E-cadherin and N-cadherin on the MSCs. The estimated 
heterophilic binding affinity is 1.95±0.07 x10-5 µm2, indicating that E-cadherin on RBCs (160 
cadherin/µm2) bind N-cadherins expressed on MSCs with a lower affinity.  
To compare binding between N-cadherin on MSCs and the recombinant N-cadherin fragment N-
cad EC1-2, which forms both X- and strand swapped dimers, we measured binding affinities 
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between red blood cells modified with N-cad EC1-2 and red blood cells modified with either of 
the three N-cadherin fragments described in this study. The 2D affinity measured between identical 
N-cad EC1-2 fragments (36 cadherin/µm2) was 4.0 ± 0.1 x10-5 µm2, which is similar to that 
between red blood cells modified with N-cad EC1-5 and N-cad EC1-2 (p>0.05, n=3 replicates) 
shown in Table 2.2 and Figure 2.3. In addition, N-cad EC1-2 bound the HAVDI peptide with a 
2D affinity of 4.50 ± 0.07 x10-5 µm2 (Table 2.3).  
2.6.2 N-cadherin binding pocket sequence HAVDI confers N-cadherin binding specificity  
E and N-cadherins belong to the most studied type of classical cadherins, which are similar in 
structure and their binding pocket is highly conserved consisting of the sequence HAV (Brieher et 
al., 1996; Brieher et al., 2003). To investigate the specificity of N-cadherin binding, the binding 
affinity between full length N-cadherin (26 peptides/µm2) and HAVDI was (18 peptides/µm2) 
measured and found to be 4.22 ± 0.07 x10-5 µm2, which is significantly higher than the binding 
affinity of 1.51 ± 0.06 x10-5 µm2 between E-cadherin (42 cadherin/µm2) and HAVDI (53 
peptides/µm2) (Table 2.7 and Figure 2.8). The HAVDI peptides did not bind to each other 
(Figure 2.7). In addition, the scrambled peptide only bound non-specifically to RBCs modified 
with N-cad EC1-5 or N-cad EC1-2 (Figure 2.7).   
In  order  to  find  out  the  presence  of  these  motifs  across  species,  we  matched  the  N-
cadherin  sequence  from  data  base  provided  by  NCBI  by  using  Basic  Local  Alignment  
Search  Tool  (BLAST)  and  found  that  these  sequences  are  present  in  the  binding  pocket  
of  N-cadherins  in  human,  mouse,  rat,  bovine  and  orangutan,  with  the  exception  in  chicken.  
Chicken N-cadherin has only INPISGQ and HAVD sequence. E-cadherin,  although  having  the  
HAV  sequence,  it  doesn’t  have  either  the  INPI  or  the  VDI  sequence,  which  could  possibly  
lead  to  a  lesser  binding  affinity  with  the  HAVDI  peptide  construct (Appendix E).  
2.6.3 N-cadherin adhesive domain EC1-2 and binding pocket motif HAVDI alone can mimic 
N-cadherin mediated adhesion 
The two outermost extracellular domains (EC1 and EC2) form the adhesive dimer interface of 
classical cadherin. The results shown in Table 2.3 demonstrate that the full length soluble form of 
N-cadherin can bind with either N-cadherin on MSCs or soluble N-cadherin Fc (N-cad EC1-5 Fc) 
with an affinity that is not significantly different.  
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To test whether N-cad EC1-2 interaction with N-cad EC1-2 or HAVDI peptides is similar to that 
of the N-cad EC1-2 interaction with N-cad EC1-5, red blood cells were labeled with biotinylated 
N-cad EC1-2 and HAVDI peptide having the cell surface densities of 36 and 38 cadherin/µm2, 
respectively. The kinetic profiles were monophasic for both cases (Figure 2.4). Fitting to the 
model of probabilistic kinetic equation 1, the binding affinity between EC1-2 domains was 4.0 ± 
0.1 x10-5 µm2 which is not significantly different than that of the full length N-cadherin construct 
(N-cad EC1-5 Fc), listed in Table 2.3. The HAVDI peptides did not bind to each other at all 
(Figure 2.7). The binding affinity between N-cad EC1-2 and HAVDI was also similar to that of 
the full length N-cadherin construct (4.50 ± 0.07 x10-5 µm2).  
2.7 Discussion 
The two dimensional binding affinity measurements demonstrated that all three N-cadherin 
fragments exhibit statistically similar affinities for N-cadherin on MSCs and that the cytoplasmic 
or transmembrane domain of wild type N-cadherins did not influence the binding affinity 
measurements. Also, although prior studies have showed that heterophilic binding between E and 
N-cadherin take place, in this study it was found that the E-cadherin didn’t contribute to the N-
cadherin mediated adhesion when N-cadherin was also present. Perhaps, this is the case because 
the number of E-cadherin (7±3 cadherin/µm2) expressed on MSCs were significantly (n≥5 and 
p≤0.05) smaller than that of N-cadherins (21±1 cadherin/µm2). But further studies with sorting 
for cells that express similar levels of E and N-cadherins need to be done to confirm the 
contribution of E-cadherin in binding with HAVDI peptide which represents the binding pocket 
sequence of N-cadherin.  Makagiansar et al.  (2001)  showed  that  binding  between  E-cadherins  
can  be  modulated  by  changing  the  amino  sequence  after the  HAV  sequence in protein. For 
example, Ac-SHAVAS-NH2 and  Ac-SHAVSA-NH2  were  found to be more  effective  than Ac-
SHAVSS-NH2  at mimicking  the  binding  pocket  sequence  of  E-cadherin in this study.  As 
such, this difference in the amino acid sequence (i.e.  HAVDI  for  N-cadherin  and  HAVSS  for  
E-cadherin)  might  be responsible for  the ~2  fold  decrease  in  binding  affinity  with  HAVDI  
construct observed in Micropipette Aspiration Assay (MPA).  
In order to show the contribution of E-cadherin to the overall binding affinity of MSC cells to N-
cadherin fragments, MPA measurements between only E-cadherin EC1-5 vs. HAVDI showed that 
the binding affinity is ~2 fold lower than that of the N-cadherin EC1-5 vs. HAVDI. Therefore, 
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having a significantly small number of E-cadherins present on MSCs that have smaller affinity for 
HAVDI peptide than N-cadherins, might be the reason why we do not see a difference in overall 
binding even when E-cadherins were blocked by DECMA-1. The lower affinity of E-cadherin for 
HAVDI peptide also reveals the importance of the flanking amino acids next to HAV sequence 
that is conserved across species. These studies also indicate the importance of the binding pocket 
sequence in cadherin specificity.  
2.8 Conclusion and future work  
In recent years the importance of design of small soluble forms of adhesion molecules, resembling 
N-cadherins for promoting axonal growth, neurite outgrowth as well as maintaining adhesion with 
other cadherins and/or substrates through integrins has emerged. In an attempt to justify the use of 
small peptide sequence HAVDI, also known as the binding pocket sequence of N-cadherin, to 
mimic and recapitulate full length N-cadherin mediated adhesion, 2D binding affinities of N-
cadherin fragments of the extracellular domains were measured and compared. Form the 
similarities observed in binding affinity, we showed that the HAVDI sequence alone can 
apparently mimic trans binding affinity of the full length N-cadherin. Moreover, these results 
demonstrate quantitatively that the amino acids flanking the HAVDI sequence have a significant 
impact on the binding affinity of E and N-cadherins. The latter behavior could explain the 
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2.9 Figures  
 
Figure 2.1: Schematic of the micropipette setup. The D1 or MSC cell expressing membrane 
bound wild type N-cadherin is aspirated using a micropipette of diameter ~ 7.2 µm2. (a) On the 
other micropipette of diameter ~1.5 µm2 a red blood cell (RBC) modified with N-cadherin mimetic 
constructs is aspirated. For affinity measurement experiments, N-cadherin EC1-5 Fc is covalently 
attached with (b) anti-Fc antibody on the RBC membrane and (c, d) both HAVDI peptide and 
EC1-2 (biotinylated) are attached to streptavidin coated RBC membrane. 
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Figure 2.2: Binding probability versus contact time between RBCs displaying different N-
cadherin fragments and MSCs. Data shown include measurements with RBCs displaying N-cad 
EC1-5 fragments (black circles); N-cad EC1-2 (black diamonds); and HAVDI (black squares). 
Controls shown include measurements between MSCs and RBCs modified with either anti-Fc 
antibody (open circles) or streptavidin (open squares). The data shown are the average and s.e.m. 
The dashed and solid lines through the data are the nonlinear least squares fits of the data for EC1 
binding to Eq. 1, with best fit parameters given in the text and in Table 2.1.  
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Figure 2.3: Binding probability versus contact time between N-cadherin fragments on. (a) 
Binding probability versus contact time between RBCs displaying different N-cadherin fragments. 
Data shown include measurements between N-cad EC1-5 fragments on opposing RBCs (black 
diamonds); between N-cad EC1-5 and N-cad EC1-2 (black triangles); between N-cad EC1-5 and 
HAVDI (black circles); and between RBCs without N-cad fragments (open squares). The data 
shown are the average and s.e.m. The cadherin densities on the two cells are given in Table 2.2. 
The dashed and solid lines through the data are the nonlinear least squares fits of the data (EC1 
binding step) to Eq. 1, with best-fit parameters given in the text and in Table 2.2.  
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Figure 2.4: Binding probability versus contact time between N-cadherin EC1-2 fragments 
immobilized on opposing red blood cell (RBC) surfaces. Data shown include measurements 
between N-cad EC1-2 and N-cad EC1-2 (black squares); between N-cad EC1-2 and HAVDI (black 
circles). The data shown are the average and s.e.m. The cadherin densities on the two cells are 
given in Table 2.3. The solid and the dashed lines through the data are the nonlinear least squares 
fits of the data (EC1 binding step) to Eq.1, with best-fit parameters given in the text and in Table 
2.3. The binding interactions are monophasic in absence of the other extracellular domains. 
Controls shown include measurements between streptavidin-labeled RBCs, devoid of ligands on 
their surfaces.   
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Fig. 2.5: Binding probability versus contact time between MSCs and E-cadherins 
immobilized on opposing red blood cell (RBC) surfaces with and without E-cadherin 
blocking antibody. Data shown here include measurement between wild type E-cadherin and N-
cadherin expressed on MSCs and E-cad EC1-5 on opposing RBCs (black squares); between MSCs 
in which E-cadherin was blocked by anti-E-cadherin i.e. DECMA-1 and E-cad EC1-5 (black 
circles). The data shown are the average and s.e.m. The cadherin densities on two cells are given 
in Table 2.4. The solid and dashed lines through data are the nonlinear lease squares fits to Eq.1, 
with best-fit parameters are given in Table 2.4. Controls shown include measurements between 
MSCs and bare RBCs, devoid of any ligands (open triangle) and between MSCs and E-cad EC1-
5 immobilized on RBCs that are blocked by DECMA-1.   
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Figure 2.6: Binding probability versus contact time between N-cad EC1-5 immobilized on 
opposing red blood cell (RBC) surfaces and MSCs with and without blocking E-cadherins. 
Data shown include measurements between MSCs after blocking E-cadherin with an anti-E-
cadherin antibody (+DECMA-1) and N-cad EC1-5 (black squares); between MSCs after blocking 
E-cadherin with an anti-E-cadherin antibody (+DECMA-1) and HAVDI immobilized on RBCs 
(black triangles). The data shown are the average and s.e.m. The cadherin and/or peptide densities 
on the two cells are given in Table 2.5. The solid and the dashed lines through the data are the 
nonlinear least squares fits of the data (EC1 binding step) to Eq.1, with best-fit parameters given 
in the text and in Table 2.5. Controls shown include measurements between MSCs and E-cad EC1-
5 immobilized on RBCs that are blocked by DECMA-1 (black diamonds) 
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Figure 2.7: The non-specific binding of the scrambled peptide (Ac-AGVGDGGGKC) with 
N-cadherin EC1-5, N-cadherin EC1-2 and HAVDI peptides immobilized on RBCs. The 
numbers in the parentheses represent the surface density of the constructs on modified RBC 
surfaces. Data shown here include measurements between scrambled peptides and N-cad EC1-2 
(black diamonds); scrambled peptides and N-cad EC1-5 (black squares); scrambled peptides and 
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Figure 2.8: Binding probability versus contact time between biotinylated HAVDI peptides 
immobilized on RBCs and full length E and N-cadherins immobilized on opposing RBCs. 
Data shown include measurements between HAVDI and E-cad EC1-5 (black circles); between  
HAVDI and N-cad EC1-5 (black diamonds). The data shown are the average and s.e.m. The 
cadherin densities on the two cells are given in Table 2.6. The solid and the dashed lines through 
the data are the nonlinear least squares fits of the data (EC1 binding step) to Eq.1, with best-fit 
parameters given in the text and in Table 2.6. Controls shown include measurements between 
streptavidin-labeled RBCs and E-cad EC1-5 (open circles) and N-cad EC1-5 on RBCs (open 
diamonds).   
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2.10 Tables 
Table 2.1: Best fit parameters from nonlinear least squares fits of N-cadherin binding between 
RBCs modified with N-cad EC1-5 and MSC cells expressing wild-type N-cadherins 












MSC N-cad WT 20 RBC N-cad EC1-5 53 4.06 ± 0.02 
37 N-cad EC1-2 40 4.0 ±  0.1 
21 HAVDI 52 4.16 ± 0.08 
 
Table 2.2: Best fit parameters from nonlinear least squares fits of N-cadherin binding between 
RBCs modified with N-cad EC1-5, N-cad EC1-2, or HAVDI 





















N-cad EC1-5 38 4.1 ± 0.1 
26 N-cad EC1-2 40 4.06 ± 0.08 
60 HAVDI 18 4.22 ± 0.07 
 
Table 2.3: Binding affinity measurements from micropipette aspiration assay between N-
cadherin constructs that are immobilized on modified red blood cells.  




Cell 2 Ligand 2 




RBC N-cad EC1-2 
40 
RBC 
N-cad EC1-5 26 4.06 ± 0.01 
36 N-cad EC1-2 36 4.0 ± 0.1 
38 HAVDI 38 4.50 ± 0.07 
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Table 2.4: Comparison of binding affinity between E-cadherin expressing MSCs with E-cadherin 
EC1-5 on RBCs in the presence of DECMA-1, an E-cadherin blocking antibody. 
Cell 1 Ligand 1 
Ligand 1 Density 
(number/ µm2) 
Cell 2 Ligand 2 




MSC WT 21 RBC E-cad EC1-5 46 4.30± 0.02 
(E-cad blocked) 21 RBC E-cad EC1-5 160 1.95 ±0.07 
 
Table 2.5: Comparison of binding affinity between E-cadherin expressing MSCs with N-cadherin 
EC1-5 on RBCs in the presence and absence of DECMA-1, an E-cadherin blocking antibody. 












N-cad WT 20 RBC 
N-cad EC1-5 
53 4.06 ± 0.02 
(E-cad blocked) 20  28 4.04 ± 0.02 
N-cad WT 21 RBC 
HAVDI 
52 4.16 ± 0.01 
(E-cad blocked) 88  15 4.16 ± 0.01 
 
Table 2.6: Comparison of binding affinity between HAVDI peptide and N and E-cadherin on 
RBCs  




Cell 2 Ligand 2 




RBC N-cad EC1-5 26 RBC HAVDI 18 4.22 ± 0.07 
RBC    E-cad EC1-5 42 RBC HAVDI 53 1.51 ± 0.06 
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Appendix A. Micropipette aspiration system 
A.1 The micropipette setup 
The micropipette system used in this study is a house designed and built system by Dr. Cheng 
Zhu’s lab. The system consists of optical microscopy with camera, micromanipulation and 
pressure regulation subsystems.   
The optical microscope is a Zeiss inverted microscope (Axiovert 200M, NA: 0.55, WD: 26mm; 
Oberkocan, Germany) with a 100xoil immersion, 1.25 N.A. objective and integrated with a HAL 
100 Halogen Illuminator. Diffraction is minimized with a green light (546-nm wavelength) band-
pass (5-nm bandwidth) filter that also reduces any photochemical damage to the RBC. The 
microscope is interfaced with a CCD camera (Pike, Allied Vision Technologies, PA). A digital 
image processor (model DSP-2000; Dage-MTI) is used to enhance the image. The signal also 
passes through a digital voltage multiplexer (model 401; Vista Electronics, Ramona, CA), which 
allows video integration and display of a timer on a screen. LabView allows integration of the 
camera recordings, as well as the piezocontroller with user interface on computer.  
 
Figure A.1: (A) Micropipette Aspiration Assay setup and (B) a zoomed in view of two 
micropipettes focused on the microscope stage.  




Figure A.2: Counting of adhesion binding events. (A) Cells are in contact; (B) During 
detachment, the right pipette pulls away; (C) Deformation around the test cell (left) indicates 
binding event.  
 
Figure A.3: A hypothetical cell-binding probability versus cell-cell contact time between a 
test cell and modified red blood cell. A rapid initial increase in binding probability to P1 = 0.45 
is followed by a delay and then a second, slower increase to a higher binding probability at P2 = 
0.68 (dashed line). The solid line is a fit of the initial binding data to a kinetic model for strand 
dimerization. 
 
Each pipette can be coarsely manipulated by a mechanical drive mounted on the microscope (see 
Figure A.1, labeled as micropipette holder and manipulator) and finely positioned with a three-
axis hydraulic micromanipulator (Model: M-461, Newport) on an air suspension vibration 
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isolation table (Technical Manufacturing Corporation, MA) in order to avoid vibration of 
micropipettes during the experiment. The right one is connected to a piezotranslator (E-665 Piezo 
Amplifier, PI, CA), which allows the micropipette to move in X-direction. Thus, the rigid 
micropipette (left) holding a test cell (RBC or MSC) come in contact with a RBC held by the 
moving (right) micropipette (Figure A.2). The contact time as well as the contact area can be 
controlled by Labview commands of computer. A hydraulic line connects the micropipette holder 
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Appendix B: Pulling micropipettes and microforging  
Sutter Instrument, The P-97 Flaming/Brown type micropipette puller was used for fabricating 
micropipettes (Single-Barrel Standard Borosilicate Glass Tubes, World Precision Instruments, 
Sarasota, FL, USA) of the following specifications: 
Item ID Length OD (mm) ID (mm) 
1B100F-4   4 in. (100mm) 1.0 0.58 
 
Program number 55 (Type D Heat (Ramp+10), Pull (90), Vel (90), Time (175), Pressure (400), 
Loops (1)) was used to pull pipettes. Next, a house-built microforge (Micro Forge, MF-900, 
Narishige, Japan) was used to break the tip of the micropipette in order to achieve a flush tip with 
the desired diameter (in our case, ~3 µm for aspirating RBC and ~6 µm aspirating MSCs). The 
micropipette tips are held by a clamp while keeping it just over a platinum wire containing a glass 
bead (adapted from the laboratory of Robert M. Hochmuth, Duke University, Durham, NC). Then 
the platinum wire is heated up by passing electricity through it and once heated up (indicated by 
the orange glow of the glass bead) the micropipette tip, at the diameter desired to be cut, is lowered 
down to touch the bead and lifted up promptly so that it snaps and breaks. In order to make sure 
that the tip is not blocked, water/buffer is pushed through the pipette by using a syringe with copper 
needle. After that, the pipette is mounted on the pipette holder, directed on the stage of the 
microscope (Figure A.1).  
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Figure B.1: Micropipette pulling instrument by Sutter Instrument Co. 
 
Figure B.2: Micropipettes of OD of 1 mm and ID 0.58 mm and the tip being ~3 µm for 
aspirating red blood cells and MSCs after microforging. 
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Figure B.3: Microforger for making micropipettes of desired diameters. (A) Different parts 
of MF-900 Microforger; (B) Micropipette to be cut is held over a glass bead on platinum wire; (C) 
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Appendix C: Flow cytometry  
C.1 Data collection by LSR II Flow Cytometer and analysis of data 
Flow cytometer allows analysis of multiple parameters (e.g. shape, size, number of target etc.) of 
individual cells in a heterogeneous population. This analysis is done by passing thousands of cels 
per second through a laser beam and capturing the light that emerges from each cells as it passes 
through. The data gathered can be analyzed statistically by flow cytometry software to report 
cellular characteristics such as size, complexity, phenotype and health.  
The fluidic system allows samples pass into the interrogation point (the point at which the path 
becomes narrow, thus allowing hydrodynamic focusing in order to make sure that the particles or 
cells pass through the laser beam one at a time). The interrogation point is the heart of the system 
because this is where the laser beam and samples intersect, and also data are collected.  
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For determining N and E-cadherin densities expressed on MSCs, around 4x104 cells were counted 
and suspended in 300 µl PBS solution and incubated with the appropriate primary and secondary 
antibody (each incubation duration was ~45 minutes at 4o C). The solutions were transferred into 




Figure C.2: Snapshot of median values calculated from MSCs labeled with Anti-N-cadherin 
antibody and DECMA-1 antibody to estimate N and E-cadherin density respectively.  
 
C.2 Standard calibration beads for Alexa 647 
Quantum™ MESF (Molecules of Equivalent Soluble Fluorochrome) microsphere kits from Bangs 
Laboratories, Inc. was purchased for standardization of fluorescence intensity units for 
applications in quantitative fluorescence cytometry. The standard Alexa 647 beads were run on 
the same day using the same settings as stained cell samples to establish a calibration curve relating 
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instrument channel values to standardized fluorescence intensity (MESF) units. Because 
Quantum™ MESF microspheres are surface labeled with the actual fluorochromes (in our case 
Alexa 647) that are used to stain cells in flow cytometry, the standards are environmentally 
responsive (e.g. to pH, temperature etc.), and quantitative assignments are truly relevant. 
Flow cytometry is a technique for determining fluorescently labeled species that are expressed on 
cells. For determining N and E-cadherin densities on MSCs as well as modified RBCs, LSR II by 
BD Biosciences.  
 
Figure C.3: Calibration of standard Alexa 647 beads by using data sheet provided by the 
manufacturer   
The calibration curve is obtained by plotting the median intensity determined with five, standard 
fluorescent bead populations: 1 – Blank microsphere population and 4 – Microsphere populations 
surface labeled with increasing amounts of the specified fluorochrome. These populations are 
calibrated in MESF units. 
Using the excel sheet provided by the calibration bead company, Bangs Laboratories Inc, the 
molecules of equivalent soluble fluorochrome (MESF) values (approximately the number of 
antibodies), were converted into surface density (cadherins/area). This was done by dividing 
MESF by the estimated surface area of the cell or bead used for the analysis, which is 768 µm2 for 
the MSCs and 168 µm2 for RBCs.  
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Appendix D: Human blood purification  
Human blood was collected from healthy volunteers by the trained phlebotomists at the 
Community Blood Services of Illinois (CBSI) in Champaign. Red blood cells were isolated from 
whole blood and purified according to the approved Institutional Review Board at the University 
of Illinois Urbana-Champaign (IRB protocol # 08669). The isolation and purification of human 
red blood cells protocol is based on protocol was published by Zarnitsyna and Zhu in 2011 and 
later modified by Langer et al., 2012 is given below:  
First, after collection of the whole blood, it was stored and transported in Vacutainer vials (coated 
with EDTA to prevent coagulation).  Inside a Biosafety Level II certified cell culture hood, 12 ml 
of Histopaque 1119 (Sigma-Aldrich, St Louis, MO) and 8 ml human blood (in 7 ml of 0.9 w/v% 
NaCl) was measured out. The blood-saline solution was then slowly added to the tube containing 
Histopaque drop by drop. Once added, there are two distinct layers consisting of transparent 
Histopaque on the bottom and red blood on the top. Then the contents of the tube was centrifuged 
at 1200 g (rcf) for 20 minutes at room temperature in a benchtop centrifuge (Elmi Centrifuge, CM-
75).  
 
Figure D.1: (A) Benchtop centrifuge for isolating red blood cells from whole blood and (B) Red 
blood cells isolated (bottom) from whole blood (top) after centrifuging for 20 mins at 1200 g (rcf).   
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The supernatant was aspirated using a glass pipette inside cell culture hood into a flask containing 
bleach (20% by volume). The remaining cells, now consisting of mostly red blood cells were re-
suspended in 6 ml of 0.9 % w/v NaCl, prior to the addition of 2 ml of 6 % w/v Dextran, to obtain 
a final concentration of 1.5% w/v. The cells were incubated at room temperature for 45 minutes, 
during which they settled to the bottom of the tube. After discarding the supernatant, the red blood 
cells (RBC) were washed twice at room temperature with 0.9 w/v% NaCl, centrifuged at 2000 
RPM for 10 minutes and re-suspended in 12 ml EAS45 (2.0 mM Adenine, 110.0 mM Dextrose, 
55.0 mM Mannitol, 50.0 mM NaCl, 10.0 mM glutamine and 20.0 mM Na2HPO4, at pH 8.0). The 
purified RBC suspension in EAS45 was stored at 4°C (Fig 2.2), and was used for up to 3 months, 
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Appendix E: Amino acid sequence of cadherins  
The following amino acid sequences were obtained from BLAST (Basic Local Alignment Search 
Tool); website: https://blast.ncbi.nlm.nih.gov/Blast.cgi  
E.1 N-cadherin EC1 sequence of human N-cadherin 
DWVIPPINLPENSRGPFPQELVRIRSDRDKNLSLRYSVTGPGADQPPTGIFIINPISGQLSVT
KPLDREQIARFHLRAHAVDINGNQVENPIDIVINVIDM 
E.2 N-cadherin EC1 sequence of mouse N-cadherin 
DWVIPPINLPENSRGPFPQELVRIRSDRDKNLSLRYSVTGPGADQPPTGIFIINPISGQL 
SVTKPLDRELIARFHLRAHAVDINGNQVENPIDIVINVIDM 
E.3 N-cadherin EC1 sequence of rat N-cadherin 
DWVIPPINLPENSRGPFPQELVRIRSDRDKNLSLRYSVTGPGADQPPTGIFIINPISGQL 
SVTKPLDRELIARFHLRAHAVDINGNQVENPIDIVINVIDM 
E.4 N-cadherin EC1 sequence of chicken N-cadherin 
DWVIPPINLPENSRGPFPQELVRIRSDRDKSLSLRYSVTGPGADQPPTGIFIINPISGQL 
SVTKPLDREQIASFHLRAHAVDVNGNQVENPIDIVINVIDM 
E.5 N-cadherin EC1 sequence of bovine N-cadherin 
DWVIPPINLPENSRGPFPQELVRIRSDRDKNLSLRYSVTGPGADQPPTGIFIINPISGQL 
SVTKPLDRELIARFHLRAHAVDINGNQVENPIDIVINVIDM 
E.6 N-cadherin EC1 sequence of orangutan N-cadherin 
DWVIPPINLPENSRGPFPQELVRIRSDRDKNLSLRYSVTGPGADQPPTGIFIINPISGQL 
SVTKPLDREQIARFHLRAHAVDINGNQVENPIDIVINVIDM 
E.6 E-cadherin EC1 sequence of human E-cadherin 
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DWVIPPISCPENEKGPFPKNLVQIKSNKDKEGKVFYSITGQGADTPPVGVFIIERETGWLK
VTEPLDRERIATYTLFSHAVSSNGNAVEDPMEILITVTDQ 
 
 
 
